| dc.contributor.author | Pan American Health Organization | |
| dc.date.accessioned | 2020-09-21T19:34:34Z | |
| dc.date.available | 2020-09-21T19:34:34Z | |
| dc.date.issued | 2020-07-13 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/2199 | |
| dc.description.abstract | Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health disorders, cancer, and asthma could result in severe disease exacerbation and potentially death. | |
| dc.language | English | |
| dc.subject | Infecctious Diseases | |
| dc.subject | COVID-19 | |
| dc.subject | Coronavirus | |
| dc.title | Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic | |
| eihealth.country | Regional, Americas (PAHO/OPS) | |
| eihealth.category | Infection prevention and control, including health care workers protection | |
| eihealth.type | WHO/PAHO Guidance | |
| eihealth.maincategory | Slow Spread / Reducir la Dispersión | |
